Nuclear Medicine Global Market Projected to Reach $8.92 billion and Growing at a CAGR of 10.55 % From 2016 to 2022

Nuclear Medicine - Global Market Outlook (2015-2022)

PUNE, INDIA, July 25, 2016 /EINPresswire.com/ -- COMPLETE REPORT DETAILS @ https://www.wiseguyreports.com/reports/562739-nuclear-medicine-global-market-outlook-2015-2022

According to Stratistics MRC, the “Global Nuclear Medicine Market is valued at $4.42 billion in 2015 and is expected to grow at a CAGR of 10.55 % to reach $8.92 billion by 2022.” Rising demand from emerging nations and the growing incidence of cardiovascular ailments and cancers are some of the key factors driving the market growth. Conversely, strict government regulations and competition from conventional diagnostic methods are hampering the market. Furthermore, technological advancements in neurological applications are anticipated to create ample of opportunities for the market in the future.

For more information or any query mail at sales@wiseguyreports.com

North America is the largest market in terms of revenue in 2015 due to several technological advancements within the region. However, Asia Pacific is poised to grow at a faster pace due to the increasing incidence of neurological and cardiovascular diseases and cancer. Various new products are being launched together with the several technological advancements. Thus, new product launch is the key strategy followed by the players to gain the traction in the market.
Some of the key players in global Nuclear Medicine market are Advanced Accelerator Applications S.A., Ashby Gorman Baker Ltd, Bayer Healthcare, Bracco Imaging S.P.A, Cardinal Health, Digirad, Eczcibasi-Monrol Nuclear Products, GE Healthcare, IBA Molecular Imaging, Lantheus Medical Imaging, Mallinckrodt PLC, Mediso Ltd., Nordion, Inc., Philips Healthcare and Siemens Healthcare.

REQUEST FOR SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/562739-nuclear-medicine-global-market-outlook-2015-2022

Applications Covered:
• Therapeutics
o Bone Metastasis
o Endocrine Tumors
o Lymphoma
o Thyroid
o Nephrology
o Cardiology
o Neurology
o Other Therapeutic Applications
• Diagnostics
o Positron emission tomography (PET)
o Single Photon Emission Computed Tomography (SPECT)
Types of Nuclear Medicine Covered:
• Nuclear Medicine Therapeutic Isotopes
o Alpha Emitters
o Brachytherapy
o Beta Emitters
• Nuclear Medicine/Radiopharmaceuticals Diagnostics
o Positron emission tomography (PET) Radiopharmaceuticals
o Single photon emission tomography (SPECT)
Procedure Volumes Covered
• Therapeutic
o Alpha Emitters
o Beta Emitters
o Brachytherapy
• Diagnostics
o Single photon emission tomography (SPECT) Radiopharmaceuticals
o Positron emission tomography (PET) Radiopharmaceuticals
End Users Covered:
• Therapeutic
o Alpha Emitters
o Beta Emitters
o Brachytherapy
• Diagnostics
o Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
o Positron Emission Tomography (PET) Radiopharmaceuticals
Stable Isotopes Covered:
• Sulphur (S-32)
• Oxygen (O-18)
• Nitrogen (N-15)
• Deuterium (D2)
• Carbon (C-13)
• Other Stable Isotopes
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

BUY NOW @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=562739

Table Of Content

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Nuclear Medicine Market, By Application
5.1 Introduction
5.2 Therapeutics
5.2.1 Bone Metastasis
5.2.2 Endocrine Tumors
5.2.3 Lymphoma
5.2.4 Thyroid
5.2.5 Nephrology
5.2.6 Cardiology
5.2.7 Neurology
Continue…..
For more information or any query mail at sales@wiseguyreports.com

CHECK DISCOUNT ON THIS REPORT @ https://www.wiseguyreports.com/check-discount/562739-nuclear-medicine-global-market-outlook-2015-2022

Contact Us:

NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
16468459349
email us here